Philipp N. Sander is an investor at SOSV, where he leads the therapeutics and human health practice. He focuses on supporting startups in human or planetary health.

Sander's background includes a ChemBio PhD from Scripps Research. His investment roles extend to being an Investor & Advisor for Reactosome and Stream Genomics, and he also serves as a Board Observer at Oncoprecision. He previously held roles as a Venture Fellow at SOSV SF & NY.